Sulfamerazine

CAS No. 127-79-7

Sulfamerazine( Sulfamerazine | Mebacid | Methylsulfadiazine )

Catalog No. M11153 CAS No. 127-79-7

Sulfamerazine(RP-2632) is a sulfonamide antibacterial.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 33 In Stock
500MG 52 In Stock
1G 87 In Stock

Biological Information

  • Product Name
    Sulfamerazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfamerazine(RP-2632) is a sulfonamide antibacterial.
  • Description
    Sulfamerazine(RP-2632) is a sulfonamide antibacterial.(In Vitro):Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA.
  • In Vitro
    Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA.
  • In Vivo
    ——
  • Synonyms
    Sulfamerazine | Mebacid | Methylsulfadiazine
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    DHPS
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    127-79-7
  • Formula Weight
    264.3
  • Molecular Formula
    C11H12N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 53 mg/mL (200.52 mM)
  • SMILES
    O=S(C1=CC=C(N)C=C1)(NC2=NC=CC(C)=N2)=O
  • Chemical Name
    4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hong YL, et al. Antimicrob Agents ChemOthers. 1995, 39(8):1756-63. 2. Friaza V, et al. Postgrad Med. 2010, 122(6):24-8. 3. Thijssen HH. Anal Biochem. 1973, 53(2):579-85. 4. Rajendiran N, et al. Spectrochim Acta A Mol Biomol Spectrosc, 2014, 124, 441-450. 5. De Backer P, et al. Am J Vet Res, 1982, 43(10), 1744-175
molnova catalog
related products
  • Imiquimod maleate

    Imiquimod maleate (R 837 maleate) is a toll-like receptor 7 (TLR7) agonist and immune response modifier with antiviral and antitumor effects.

  • UVI 3003

    UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits Xenopus and human RXRα in Cos7 cells (IC50s: 0.22 and 0.24 μM, respectively).

  • Dilmapimod

    Dilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.